Ligand validation:4GVH

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4GVH_MES_A_402	73%	9%	0.12	0.949	2.23	2.4	1	4	0	0	100%	0.77
4HZM_MES_B_402	78%	11%	0.109	0.951	2.02	2.33	1	4	0	0	100%	0.78
4GVF_MES_B_403	75%	11%	0.123	0.957	2.06	2.29	1	3	0	0	100%	0.9408
4GVG_MES_B_7001	72%	11%	0.119	0.942	2.1	2.23	1	6	0	0	100%	0.77
4GVI_MES_B_403	29%	10%	0.183	0.839	2.18	2.26	1	5	0	0	100%	0.69
8AJQ_MES_H_201	100%	39%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
4NWT_MES_L_301	100%	25%	0.045	0.99	1.24	1.94	2	4	0	0	100%	1
4S23_MES_B_502	100%	24%	0.05	0.993	1.97	1.34	1	1	0	0	100%	1
5NJ9_MES_A_502	99%	61%	0.049	0.988	0.71	0.74	-	1	0	0	100%	1
4BRG_MES_B_1399	99%	13%	0.061	0.988	1.72	2.42	3	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.